GO:0006915 | apoptotic process | 100.0% (2/2) | 8.35 | 9e-06 | 0.004141 |
GO:0030282 | bone mineralization | 50.0% (1/2) | 11.25 | 0.000409 | 0.007253 |
GO:0040016 | embryonic cleavage | 50.0% (1/2) | 11.25 | 0.000409 | 0.007253 |
GO:0060218 | hematopoietic stem cell differentiation | 50.0% (1/2) | 11.25 | 0.000409 | 0.007253 |
GO:0070516 | CAK-ERCC2 complex | 50.0% (1/2) | 11.25 | 0.000409 | 0.007253 |
GO:0012501 | programmed cell death | 100.0% (2/2) | 5.58 | 0.000438 | 0.007471 |
GO:0033683 | nucleotide-excision repair, DNA incision | 50.0% (1/2) | 11.08 | 0.00046 | 0.007555 |
GO:0002803 | positive regulation of antibacterial peptide production | 50.0% (1/2) | 11.45 | 0.000358 | 0.007555 |
GO:0002805 | regulation of antimicrobial peptide biosynthetic process | 50.0% (1/2) | 11.45 | 0.000358 | 0.007555 |
GO:0002807 | positive regulation of antimicrobial peptide biosynthetic process | 50.0% (1/2) | 11.45 | 0.000358 | 0.007555 |
GO:0002808 | regulation of antibacterial peptide biosynthetic process | 50.0% (1/2) | 11.45 | 0.000358 | 0.007555 |
GO:0006963 | positive regulation of antibacterial peptide biosynthetic process | 50.0% (1/2) | 11.45 | 0.000358 | 0.007555 |
GO:0000112 | nucleotide-excision repair factor 3 complex | 50.0% (1/2) | 11.45 | 0.000358 | 0.007555 |
GO:0010525 | regulation of transposition, RNA-mediated | 50.0% (1/2) | 11.45 | 0.000358 | 0.007555 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 50.0% (1/2) | 10.67 | 0.000614 | 0.008499 |
GO:0000019 | regulation of mitotic recombination | 50.0% (1/2) | 10.67 | 0.000614 | 0.008499 |
GO:0002813 | regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 50.0% (1/2) | 12.67 | 0.000153 | 0.0085 |
GO:0006964 | positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 50.0% (1/2) | 12.67 | 0.000153 | 0.0085 |
GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway | 50.0% (1/2) | 12.67 | 0.000153 | 0.0085 |
GO:0000717 | nucleotide-excision repair, DNA duplex unwinding | 50.0% (1/2) | 12.67 | 0.000153 | 0.0085 |
GO:0032289 | central nervous system myelin formation | 50.0% (1/2) | 12.67 | 0.000153 | 0.0085 |
GO:0043249 | erythrocyte maturation | 50.0% (1/2) | 12.67 | 0.000153 | 0.0085 |
GO:0045951 | positive regulation of mitotic recombination | 50.0% (1/2) | 12.67 | 0.000153 | 0.0085 |
GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.008597 |
GO:0005675 | transcription factor TFIIH holo complex | 50.0% (1/2) | 10.8 | 0.000563 | 0.008597 |
GO:0048513 | animal organ development | 100.0% (2/2) | 5.14 | 0.000801 | 0.008875 |
GO:0002225 | positive regulation of antimicrobial peptide production | 50.0% (1/2) | 10.35 | 0.000767 | 0.008946 |
GO:0002760 | positive regulation of antimicrobial humoral response | 50.0% (1/2) | 10.35 | 0.000767 | 0.008946 |
GO:0048820 | hair follicle maturation | 50.0% (1/2) | 10.35 | 0.000767 | 0.008946 |
GO:0008219 | cell death | 100.0% (2/2) | 5.34 | 0.000606 | 0.008954 |
GO:0051726 | regulation of cell cycle | 100.0% (2/2) | 5.15 | 0.000791 | 0.008988 |
GO:0002786 | regulation of antibacterial peptide production | 50.0% (1/2) | 10.45 | 0.000716 | 0.009065 |
GO:0043949 | regulation of cAMP-mediated signaling | 50.0% (1/2) | 10.45 | 0.000716 | 0.009065 |
GO:0032288 | myelin assembly | 50.0% (1/2) | 10.45 | 0.000716 | 0.009065 |
GO:0000439 | transcription factor TFIIH core complex | 50.0% (1/2) | 10.17 | 0.00087 | 0.009397 |
GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process | 50.0% (1/2) | 10.08 | 0.000921 | 0.009712 |
GO:0061057 | peptidoglycan recognition protein signaling pathway | 50.0% (1/2) | 11.67 | 0.000307 | 0.009714 |
GO:0089720 | caspase binding | 50.0% (1/2) | 11.67 | 0.000307 | 0.009714 |
GO:0006362 | transcription elongation by RNA polymerase I | 50.0% (1/2) | 11.67 | 0.000307 | 0.009714 |
GO:1903859 | regulation of dendrite extension | 50.0% (1/2) | 11.93 | 0.000256 | 0.010303 |
GO:1903861 | positive regulation of dendrite extension | 50.0% (1/2) | 11.93 | 0.000256 | 0.010303 |
GO:0071817 | MMXD complex | 50.0% (1/2) | 11.93 | 0.000256 | 0.010303 |
GO:0031214 | biomineral tissue development | 50.0% (1/2) | 9.86 | 0.001074 | 0.010575 |
GO:0035315 | hair cell differentiation | 50.0% (1/2) | 9.86 | 0.001074 | 0.010575 |
GO:0110148 | biomineralization | 50.0% (1/2) | 9.86 | 0.001074 | 0.010575 |
GO:0002784 | regulation of antimicrobial peptide production | 50.0% (1/2) | 9.8 | 0.001125 | 0.010607 |
GO:0002922 | positive regulation of humoral immune response | 50.0% (1/2) | 9.8 | 0.001125 | 0.010607 |
GO:0002759 | regulation of antimicrobial humoral response | 50.0% (1/2) | 9.73 | 0.001177 | 0.010858 |
GO:0021510 | spinal cord development | 50.0% (1/2) | 9.67 | 0.001228 | 0.010877 |
GO:0022405 | hair cycle process | 50.0% (1/2) | 9.67 | 0.001228 | 0.010877 |
GO:0009650 | UV protection | 50.0% (1/2) | 9.5 | 0.001381 | 0.011543 |
GO:0043139 | 5'-3' DNA helicase activity | 50.0% (1/2) | 9.5 | 0.001381 | 0.011543 |
GO:0022404 | molting cycle process | 50.0% (1/2) | 9.55 | 0.00133 | 0.011552 |
GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 50.0% (1/2) | 9.45 | 0.001432 | 0.011749 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 50.0% (1/2) | 9.4 | 0.001483 | 0.011947 |
GO:0048863 | stem cell differentiation | 50.0% (1/2) | 9.35 | 0.001534 | 0.012138 |
GO:0002920 | regulation of humoral immune response | 50.0% (1/2) | 9.3 | 0.001586 | 0.012323 |
GO:0000109 | nucleotide-excision repair complex | 50.0% (1/2) | 9.25 | 0.001637 | 0.012501 |
GO:0006367 | transcription initiation at RNA polymerase II promoter | 50.0% (1/2) | 9.17 | 0.001739 | 0.012839 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 50.0% (1/2) | 9.17 | 0.001739 | 0.012839 |
GO:0022416 | chaeta development | 50.0% (1/2) | 9.08 | 0.001841 | 0.013371 |
GO:0002244 | hematopoietic progenitor cell differentiation | 50.0% (1/2) | 8.97 | 0.001995 | 0.013806 |
GO:0005669 | transcription factor TFIID complex | 50.0% (1/2) | 8.97 | 0.001995 | 0.013806 |
GO:0016251 | RNA polymerase II general transcription initiation factor activity | 50.0% (1/2) | 8.97 | 0.001995 | 0.013806 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 50.0% (1/2) | 8.9 | 0.002097 | 0.01429 |
GO:1901527 | abscisic acid-activated signaling pathway involved in stomatal movement | 50.0% (1/2) | 8.83 | 0.002199 | 0.014326 |
GO:0043388 | positive regulation of DNA binding | 50.0% (1/2) | 8.83 | 0.002199 | 0.014326 |
GO:0032806 | carboxy-terminal domain protein kinase complex | 50.0% (1/2) | 8.86 | 0.002148 | 0.014417 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 50.0% (1/2) | 8.73 | 0.002352 | 0.015103 |
GO:0004869 | cysteine-type endopeptidase inhibitor activity | 50.0% (1/2) | 8.64 | 0.002506 | 0.015634 |
GO:0006354 | DNA-templated transcription elongation | 50.0% (1/2) | 8.64 | 0.002506 | 0.015634 |
GO:0065009 | regulation of molecular function | 100.0% (2/2) | 4.27 | 0.002688 | 0.016538 |
GO:0032206 | positive regulation of telomere maintenance | 50.0% (1/2) | 8.47 | 0.002812 | 0.016835 |
GO:0140223 | general transcription initiation factor activity | 50.0% (1/2) | 8.47 | 0.002812 | 0.016835 |
GO:0080144 | amino acid homeostasis | 50.0% (1/2) | 8.42 | 0.002914 | 0.017214 |
GO:0045911 | positive regulation of DNA recombination | 50.0% (1/2) | 8.4 | 0.002965 | 0.017286 |
GO:0045879 | negative regulation of smoothened signaling pathway | 50.0% (1/2) | 8.37 | 0.003017 | 0.017355 |
GO:0010528 | regulation of transposition | 50.0% (1/2) | 8.21 | 0.003374 | 0.018685 |
GO:0051128 | regulation of cellular component organization | 100.0% (2/2) | 4.11 | 0.003365 | 0.018871 |
GO:0008333 | endosome to lysosome transport | 50.0% (1/2) | 8.23 | 0.003323 | 0.018874 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 50.0% (1/2) | 8.15 | 0.003527 | 0.019292 |
GO:0070534 | protein K63-linked ubiquitination | 50.0% (1/2) | 7.9 | 0.004191 | 0.021342 |
GO:0043062 | extracellular structure organization | 50.0% (1/2) | 7.9 | 0.004191 | 0.021342 |
GO:0047485 | protein N-terminus binding | 50.0% (1/2) | 7.88 | 0.004242 | 0.021356 |
GO:0002700 | regulation of production of molecular mediator of immune response | 50.0% (1/2) | 7.97 | 0.003987 | 0.02154 |
GO:0030198 | extracellular matrix organization | 50.0% (1/2) | 7.91 | 0.00414 | 0.021578 |
GO:0035264 | multicellular organism growth | 50.0% (1/2) | 7.91 | 0.00414 | 0.021578 |
GO:0008589 | regulation of smoothened signaling pathway | 50.0% (1/2) | 7.93 | 0.004089 | 0.021825 |
GO:0070062 | extracellular exosome | 50.0% (1/2) | 7.83 | 0.004396 | 0.021879 |
GO:0006352 | DNA-templated transcription initiation | 50.0% (1/2) | 7.78 | 0.004549 | 0.02239 |
GO:0002020 | protease binding | 50.0% (1/2) | 7.75 | 0.004651 | 0.022641 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 100.0% (2/2) | 3.68 | 0.006051 | 0.02291 |
GO:0031398 | positive regulation of protein ubiquitination | 50.0% (1/2) | 7.37 | 0.006029 | 0.023023 |
GO:0032392 | DNA geometric change | 50.0% (1/2) | 7.37 | 0.006029 | 0.023023 |
GO:0051101 | regulation of DNA binding | 50.0% (1/2) | 7.46 | 0.005672 | 0.02305 |
GO:2001252 | positive regulation of chromosome organization | 50.0% (1/2) | 7.46 | 0.005672 | 0.02305 |
GO:0003684 | damaged DNA binding | 50.0% (1/2) | 7.65 | 0.004957 | 0.023116 |
GO:0032204 | regulation of telomere maintenance | 50.0% (1/2) | 7.67 | 0.004906 | 0.023121 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 50.0% (1/2) | 7.68 | 0.004855 | 0.023126 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 50.0% (1/2) | 7.68 | 0.004855 | 0.023126 |
GO:0048469 | cell maturation | 50.0% (1/2) | 7.32 | 0.006233 | 0.023202 |
GO:0061135 | endopeptidase regulator activity | 50.0% (1/2) | 7.34 | 0.006182 | 0.023207 |
GO:0004866 | endopeptidase inhibitor activity | 50.0% (1/2) | 7.38 | 0.005978 | 0.023229 |
GO:0001701 | in utero embryonic development | 50.0% (1/2) | 7.4 | 0.005927 | 0.023234 |
GO:0007059 | chromosome segregation | 50.0% (1/2) | 7.4 | 0.005927 | 0.023234 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 50.0% (1/2) | 7.4 | 0.005927 | 0.023234 |
GO:0043230 | extracellular organelle | 50.0% (1/2) | 7.47 | 0.00562 | 0.02327 |
GO:0065010 | extracellular membrane-bounded organelle | 50.0% (1/2) | 7.47 | 0.00562 | 0.02327 |
GO:0002699 | positive regulation of immune effector process | 50.0% (1/2) | 7.42 | 0.005825 | 0.023457 |
GO:0010951 | negative regulation of endopeptidase activity | 50.0% (1/2) | 7.49 | 0.005569 | 0.023498 |
GO:1903561 | extracellular vesicle | 50.0% (1/2) | 7.49 | 0.005569 | 0.023498 |
GO:0007041 | lysosomal transport | 50.0% (1/2) | 7.53 | 0.005416 | 0.023524 |
GO:0007423 | sensory organ development | 50.0% (1/2) | 7.54 | 0.005365 | 0.023533 |
GO:0030490 | maturation of SSU-rRNA | 50.0% (1/2) | 7.54 | 0.005365 | 0.023533 |
GO:0002697 | regulation of immune effector process | 50.0% (1/2) | 7.28 | 0.006437 | 0.023566 |
GO:0030182 | neuron differentiation | 50.0% (1/2) | 7.29 | 0.006386 | 0.023574 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 50.0% (1/2) | 7.5 | 0.005518 | 0.023735 |
GO:0006289 | nucleotide-excision repair | 50.0% (1/2) | 7.55 | 0.005314 | 0.02378 |
GO:0070936 | protein K48-linked ubiquitination | 50.0% (1/2) | 7.57 | 0.005263 | 0.023792 |
GO:0032508 | DNA duplex unwinding | 50.0% (1/2) | 7.57 | 0.005263 | 0.023792 |
GO:0009913 | epidermal cell differentiation | 50.0% (1/2) | 7.6 | 0.005161 | 0.023817 |
GO:0006513 | protein monoubiquitination | 50.0% (1/2) | 7.23 | 0.006641 | 0.024113 |
GO:1902554 | serine/threonine protein kinase complex | 50.0% (1/2) | 7.17 | 0.006947 | 0.024619 |
GO:0071103 | DNA conformation change | 50.0% (1/2) | 7.18 | 0.006896 | 0.024635 |
GO:0010604 | positive regulation of macromolecule metabolic process | 100.0% (2/2) | 3.58 | 0.007009 | 0.024644 |
GO:0031325 | positive regulation of cellular metabolic process | 100.0% (2/2) | 3.59 | 0.006856 | 0.024693 |
GO:0030414 | peptidase inhibitor activity | 50.0% (1/2) | 7.1 | 0.007253 | 0.024714 |
GO:0007568 | aging | 50.0% (1/2) | 7.11 | 0.007202 | 0.024731 |
GO:0051099 | positive regulation of binding | 50.0% (1/2) | 7.13 | 0.007151 | 0.024748 |
GO:0003678 | DNA helicase activity | 50.0% (1/2) | 7.14 | 0.0071 | 0.024765 |
GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 50.0% (1/2) | 7.05 | 0.007507 | 0.025195 |
GO:0010466 | negative regulation of peptidase activity | 50.0% (1/2) | 7.06 | 0.007456 | 0.025215 |
GO:0044260 | cellular macromolecule metabolic process | 100.0% (2/2) | 3.51 | 0.007685 | 0.025405 |
GO:0090575 | RNA polymerase II transcription regulator complex | 50.0% (1/2) | 7.03 | 0.00766 | 0.025515 |
GO:0008022 | protein C-terminus binding | 50.0% (1/2) | 6.97 | 0.007966 | 0.025759 |
GO:1902911 | protein kinase complex | 50.0% (1/2) | 6.98 | 0.007915 | 0.025783 |
GO:0000018 | regulation of DNA recombination | 50.0% (1/2) | 6.99 | 0.007864 | 0.025806 |
GO:0061134 | peptidase regulator activity | 50.0% (1/2) | 6.93 | 0.00817 | 0.026038 |
GO:0030855 | epithelial cell differentiation | 50.0% (1/2) | 6.94 | 0.008119 | 0.026063 |
GO:0009893 | positive regulation of metabolic process | 100.0% (2/2) | 3.37 | 0.00929 | 0.029397 |
GO:0052548 | regulation of endopeptidase activity | 50.0% (1/2) | 6.72 | 0.009444 | 0.02967 |
GO:0006260 | DNA replication | 50.0% (1/2) | 6.64 | 0.010004 | 0.030775 |
GO:0008283 | cell population proliferation | 50.0% (1/2) | 6.64 | 0.010004 | 0.030775 |
GO:0043009 | chordate embryonic development | 50.0% (1/2) | 6.64 | 0.010004 | 0.030775 |
GO:0051346 | negative regulation of hydrolase activity | 50.0% (1/2) | 6.59 | 0.01036 | 0.031435 |
GO:0036211 | protein modification process | 100.0% (2/2) | 3.3 | 0.010355 | 0.031636 |
GO:0051536 | iron-sulfur cluster binding | 50.0% (1/2) | 6.53 | 0.010767 | 0.032012 |
GO:0051540 | metal cluster binding | 50.0% (1/2) | 6.53 | 0.010767 | 0.032012 |
GO:0031396 | regulation of protein ubiquitination | 50.0% (1/2) | 6.55 | 0.010665 | 0.032141 |
GO:0048639 | positive regulation of developmental growth | 50.0% (1/2) | 6.45 | 0.011429 | 0.033308 |
GO:0046872 | metal ion binding | 100.0% (2/2) | 3.21 | 0.011675 | 0.033369 |
GO:0008094 | ATP-dependent activity, acting on DNA | 50.0% (1/2) | 6.45 | 0.011378 | 0.03338 |
GO:0051054 | positive regulation of DNA metabolic process | 50.0% (1/2) | 6.45 | 0.011378 | 0.03338 |
GO:0005769 | early endosome | 50.0% (1/2) | 6.42 | 0.011632 | 0.033461 |
GO:0052547 | regulation of peptidase activity | 50.0% (1/2) | 6.42 | 0.011632 | 0.033461 |
GO:0030674 | protein-macromolecule adaptor activity | 50.0% (1/2) | 6.38 | 0.011937 | 0.033899 |
GO:0050829 | defense response to Gram-negative bacterium | 50.0% (1/2) | 6.37 | 0.012039 | 0.03397 |
GO:0030307 | positive regulation of cell growth | 50.0% (1/2) | 6.32 | 0.012497 | 0.034173 |
GO:0045861 | negative regulation of proteolysis | 50.0% (1/2) | 6.32 | 0.012497 | 0.034173 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 50.0% (1/2) | 6.32 | 0.012497 | 0.034173 |
GO:0043169 | cation binding | 100.0% (2/2) | 3.18 | 0.012223 | 0.034272 |
GO:0051865 | protein autoubiquitination | 50.0% (1/2) | 6.32 | 0.012446 | 0.034676 |
GO:1900426 | positive regulation of defense response to bacterium | 50.0% (1/2) | 6.28 | 0.012802 | 0.034792 |
GO:0034250 | positive regulation of cellular amide metabolic process | 50.0% (1/2) | 6.24 | 0.013158 | 0.035542 |
GO:0044297 | cell body | 50.0% (1/2) | 6.14 | 0.014123 | 0.037918 |
GO:0043412 | macromolecule modification | 100.0% (2/2) | 3.06 | 0.014339 | 0.038036 |
GO:0060090 | molecular adaptor activity | 50.0% (1/2) | 6.13 | 0.014276 | 0.038097 |
GO:0004386 | helicase activity | 50.0% (1/2) | 6.1 | 0.01453 | 0.038313 |
GO:0031326 | regulation of cellular biosynthetic process | 100.0% (2/2) | 3.01 | 0.015348 | 0.039077 |
GO:0010927 | cellular component assembly involved in morphogenesis | 50.0% (1/2) | 6.02 | 0.015342 | 0.039286 |
GO:0000209 | protein polyubiquitination | 50.0% (1/2) | 6.03 | 0.015291 | 0.039384 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 50.0% (1/2) | 6.03 | 0.015291 | 0.039384 |
GO:0007034 | vacuolar transport | 50.0% (1/2) | 6.04 | 0.015088 | 0.039551 |
GO:0033044 | regulation of chromosome organization | 50.0% (1/2) | 6.04 | 0.01519 | 0.039583 |
GO:0051098 | regulation of binding | 50.0% (1/2) | 5.99 | 0.015697 | 0.039737 |
GO:0009792 | embryo development ending in birth or egg hatching | 50.0% (1/2) | 5.95 | 0.016103 | 0.040533 |
GO:0010468 | regulation of gene expression | 100.0% (2/2) | 2.96 | 0.016399 | 0.040813 |
GO:0009889 | regulation of biosynthetic process | 100.0% (2/2) | 2.97 | 0.016366 | 0.040962 |
GO:0005667 | transcription regulator complex | 50.0% (1/2) | 5.89 | 0.016814 | 0.041612 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 50.0% (1/2) | 5.85 | 0.017321 | 0.042629 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 50.0% (1/2) | 5.8 | 0.017828 | 0.043635 |
GO:0019538 | protein metabolic process | 100.0% (2/2) | 2.89 | 0.018099 | 0.044053 |
GO:0140097 | catalytic activity, acting on DNA | 50.0% (1/2) | 5.77 | 0.018234 | 0.04414 |
GO:0032774 | RNA biosynthetic process | 50.0% (1/2) | 5.72 | 0.018893 | 0.045487 |
GO:0048522 | positive regulation of cellular process | 100.0% (2/2) | 2.85 | 0.019139 | 0.04583 |
GO:0004857 | enzyme inhibitor activity | 50.0% (1/2) | 5.68 | 0.019349 | 0.045838 |
GO:0010638 | positive regulation of organelle organization | 50.0% (1/2) | 5.68 | 0.019349 | 0.045838 |
GO:0005829 | cytosol | 100.0% (2/2) | 2.81 | 0.020325 | 0.047893 |
GO:0061630 | ubiquitin protein ligase activity | 50.0% (1/2) | 5.59 | 0.020666 | 0.048439 |
GO:0051171 | regulation of nitrogen compound metabolic process | 100.0% (2/2) | 2.78 | 0.02118 | 0.048868 |
GO:0006364 | rRNA processing | 50.0% (1/2) | 5.56 | 0.021122 | 0.048989 |
GO:0061659 | ubiquitin-like protein ligase activity | 50.0% (1/2) | 5.56 | 0.021071 | 0.049129 |
GO:0009738 | abscisic acid-activated signaling pathway | 50.0% (1/2) | 5.51 | 0.021881 | 0.049709 |
GO:1902532 | negative regulation of intracellular signal transduction | 50.0% (1/2) | 5.51 | 0.02178 | 0.049734 |
GO:0031625 | ubiquitin protein ligase binding | 50.0% (1/2) | 5.49 | 0.022134 | 0.049773 |
GO:1901987 | regulation of cell cycle phase transition | 50.0% (1/2) | 5.49 | 0.022134 | 0.049773 |
GO:0045927 | positive regulation of growth | 50.0% (1/2) | 5.52 | 0.021729 | 0.049876 |